Oxytocin alleviated colitis and colitis-associated colorectal tumorigenesis by targeting fucosylated MUC2
X. Wang, D. Chen, M. Guo, Y. Ning, J. Guo, J. Gao, X. Xie, D. Zhao, L. Li, S. Li, Y. Li, X. Zuo, J. Li
This study shows that oxytocin reduces colitis and CAC by enhancing MUC2 fucosylation via OXTR, suggesting it as a potential therapeutic for these conditions.
bioRxiv · Aug 17, 2023 · PreprintPhysiology